EUVIMEDEUVIMED entdecken
Crossref

Pathogenic variants in the NLRP3 LRR domain at position 861 are responsible for a boost-dependent atypical CAPS phenotype

Antoine Fayand, Margaux Cescato, Laurent Le Corre, Alexandre Terré, Margaux Wacheux, Yixiang Y J Zhu, Armelle Melet, Thomas R J Moreau, Bahram Bodaghi, Fabrice Bonnet, Didier Bronnimann, Laurence Cuisset und 14 weitere

Journal of Allergy and Clinical Immunology · 2023

DOI: 10.1016/j.jaci.2023.07.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2023. Verfasst von Antoine Fayand und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Reference Center for Autoinflammatory Diseases and Amyloid A Amyloidosis, Tenon Hospital, Sorbonne Universi…. Hauptthemen laut MEDLINE: Cryopyrin-Associated Periodic Syndromes, Exanthema, Urticaria. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cryopyrin-associated periodic syndrome (CAPS) is associated with NLRP3 pathogenic variants, mostly located in the NACHT (neuronal apoptosis inhibitor protein, MHC class 2 transcription activator, incompatibility locus protein from Podospora anserina, telomerase-associated protein) domain. Cold-induced urticarial rash is among the main clinical features. However, this study identified a series of 14 patients with pathogenic variants of the Y861 residue (p.Tyr861) of the LRR domain of NLRP3 and minimal prevalence of cold-induced urticarial rash. OBJECTIVES: This study aimed to address a possible genotype/phenotype correlation for patients with CAPS and to investigate at the cellular levels the impact of the Y861C substitution (p.Tyr861Cys) on NLRP3 activation. METHODS: Clinical features of 14 patients with CAPS and heterozygous substitution at position 861 in the LRR domain of NLRP3 were compared to clinical features of 48 patients with CAPS and pathogenic variants outside the LRR domain of NLRP3. IL-1β secretion by PBMCs and purified monocytes from patients and healthy donors was evaluated following LPS and monosodium urate crystal stimulation. RESULTS: Patients with substitution at position 861 of NLRP3 demonstrated a higher prevalence of sensorineural hearing loss while being less prone to skin urticarial. In contrast to patients with classical CAPS, cells from patients with a pathogenic variant at position 861 required an activation signal to secrete IL-1β but produced more IL-1β during the early and late phase of secretion than cells from healthy donors. CONCLUSIONS: Pathogenic variants of Y861 of NLRP3 drive a boost-dependent oversecretion of IL-1β associated with an atypical CAPS phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cryopyrin-Associated Periodic SyndromesExanthemaUrticariaHumansNLR Family, Pyrin Domain-Containing 3 ProteinPhenotype

Stichwörter der Autor:innen

CAPSIL-1LRR domainNLRP3deafnesshearing lossinflammasomeurticaria

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, human

Autor:innen und Institutionen

  • Department of Internal Medicine, National Reference Center for Autoinflammatory Diseases and Amyloid A Amyloidosis, Tenon Hospital, Sorbonne Université, Paris, France; Laboratoire de Chimie et de Biochimie Pharmacologiq…
  • Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, Centre National de la Recherche Scientifique, Université Paris Cité, Paris, France.
  • Department of Internal Medicine, National Reference Center for Autoinflammatory Diseases and Amyloid A Amyloidosis, Tenon Hospital, Sorbonne Université, Paris, France; Laboratoire Mécanismes Cellulaires et Moléculaires…
  • Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques, Centre National de la Recherche Scientifique, Université Paris Cité, Paris, France; Translational Immunology Unit, Institut Pasteur, Université P…
  • Department of Ophthalmology, Instituts Hospitalo-Universitaires FOReSIGHT, Pitié-Salpêtrière Hospital, Assistance Publique-Hȏpitaux de Paris, Sorbonne Université, Paris, France.
  • Service de Médecine Interne et Maladies Infectieuses, Hôpital Saint-André, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

Zitieren

APA

Fayand, A., Cescato, M., Le Corre, L., Terré, A., Wacheux, M., Zhu, Y. Y. J., Melet, A., Moreau, T. R. J., Bodaghi, B., Bonnet, F., Bronnimann, D., Cuisset, L., Faria, R., Grateau, G., Pillet, P., Mulders-Manders, C. M., Neven, B., Quartier, P., Richer, O., …, & Rodero, M. P. (2023). Pathogenic variants in the NLRP3 LRR domain at position 861 are responsible for a boost-dependent atypical CAPS phenotype. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2023.07.006

Vancouver

Fayand A, Cescato M, Le Corre L, Terré A, Wacheux M, Zhu YYJ, et al. Pathogenic variants in the NLRP3 LRR domain at position 861 are responsible for a boost-dependent atypical CAPS phenotype. Journal of Allergy and Clinical Immunology. 2023. doi:10.1016/j.jaci.2023.07.006

BibTeX
@article{Fayand2023,
  author = {Fayand, Antoine and Cescato, Margaux and Le Corre, Laurent and Terré, Alexandre and Wacheux, Margaux and Zhu, Yixiang Y J and Melet, Armelle and Moreau, Thomas R J and Bodaghi, Bahram and Bonnet, Fabrice and Bronnimann, Didier and Cuisset, Laurence and Faria, Raquel and Grateau, Gilles and Pillet, Pascal and Mulders-Manders, Catharina M and Neven, Benedicte and Quartier, Pierre and Richer, Olivier and Savey, Léa and Truchetet, Marie-Elise and Py, Bénédicte F and Boursier, Guilaine and Herbeuval, Jean-Philippe and Georgin-Lavialle, Sophie and Rodero, Mathieu P},
  title = {Pathogenic variants in the NLRP3 LRR domain at position 861 are responsible for a boost-dependent atypical CAPS phenotype},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2023},
  doi = {10.1016/j.jaci.2023.07.006}
}
Kostenlos starten →